{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:17:20Z","timestamp":1770837440314,"version":"3.50.1"},"reference-count":25,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IDR"],"DOI":"10.2147\/idr.s475590","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T09:10:18Z","timestamp":1725527418000},"page":"3901-3911","source":"Crossref","is-referenced-by-count":4,"title":["Retrospective Analysis of Risk Factors for Cefoperazone\/Sulbactam-Induced Thrombocytopenia in Adult Chinese Patients: A Six-Year Real-World Study"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"Bolin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianchun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanchao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12030582","volume":"12","author":"Kogilathota Jagirdhar","year":"2023","journal-title":"Antibiotics"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"856792","DOI":"10.3389\/fphar.2022.856792","volume":"13","author":"Ji","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.hoc.2007.06.005","volume":"21","author":"Visentin","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref4","first-page":"359","volume":"2022","author":"Chen","year":"2023","journal-title":"AMIA Annu Symp Proc"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11239-019-01848-3","volume":"48","author":"Beaulieu","year":"2019","journal-title":"J Thromb Thrombolysis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.transproceed.2017.02.043","volume":"49","author":"Patel","year":"2017","journal-title":"Transplant Proc"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.7324\/japs.2016.601227","volume":"6","author":"Avinash","year":"2016","journal-title":"J Appl Pharm Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"030006052311624","DOI":"10.1177\/03000605231162434","volume":"51","author":"He","year":"2023","journal-title":"J Int Med Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/14740338.2020.1713090","volume":"19","author":"Wang","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.2147\/IDR.S429706","volume":"16","author":"Miao","year":"2023","journal-title":"Infect Drug Resist"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e939203","DOI":"10.12659\/MSM.939203","volume":"29","author":"Shao","year":"2023","journal-title":"Med Sci Monit"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1182644","DOI":"10.3389\/fphar.2023.1182644","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jiac.2016.05.003","volume":"22","author":"Hanai","year":"2016","journal-title":"J Infect Chemother"},{"key":"ref14","unstructured":"National Cancer Institute, Cancer therapy evaluation program. common terminology criteria for adverse events v5.0. http:\/\/www.cancer.gov\/. Accessed 10, Feb 2017."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00228-023-03542-z","volume":"79","author":"Zhang","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/bcpt.13123","volume":"124","author":"Choi","year":"2019","journal-title":"Basic Clin Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.htct.2019.07.004","volume":"42","author":"Lima","year":"2020","journal-title":"Hematol Transf Cell"},{"key":"ref18","first-page":"AT9327","author":"Zeng","year":"2024","journal-title":"Altern Ther Health Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00228-023-03455-x","volume":"79","author":"Inoue","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.2147\/IDR.S408102","volume":"16","author":"Zhang","year":"2023","journal-title":"Infect Drug Resist"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s11096-021-01342-y","volume":"44","author":"Han","year":"2022","journal-title":"Int J Clin Pharm Net"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1055\/s-0032-1328882","volume":"38","author":"Loo","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1161\/CIRCULATIONAHA.108.827162","volume":"119","author":"Wang","year":"2009","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1182\/blood.v59.5.1001.1001","volume":"59","author":"Rozman","year":"1982","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1097\/00003246-200006000-00031","volume":"28","author":"Vanderschueren","year":"2000","journal-title":"Crit Care Med"}],"container-title":["Infection and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/95470","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/95470","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T09:10:23Z","timestamp":1725527423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/retrospective-analysis-of-risk-factors-for-cefoperazonesulbactam-induc-peer-reviewed-fulltext-article-IDR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":25,"URL":"https:\/\/doi.org\/10.2147\/idr.s475590","relation":{},"ISSN":["1178-6973"],"issn-type":[{"value":"1178-6973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}